Schein Pharmaceutical announces color caps for two ophthalmic solutions.FLORHAM PARK, N.J.--(HealthWire)--March 1, 1996--Schein Pharmaceutical Inc. today announced that both Dipivefrin Hydrochloride di·piv·e·frin hydrochloride n. An ophthalmic adrenergic that is used in drop form in the initial therapy for controlling intraocular pressure in chronic open-angle glaucoma. 0.1%, and Levobunolol Hydrochloride le·vo·bu·no·lol hydrochloride n. A beta-blocker administered as eyedrops for the treatment of chronic open-angle glaucoma and ocular hypertension. 0.25% and 0.5% Ophthalmic Solutions ophthalmic solution n. A sterile solution that is free from foreign particles and is compounded and dispensed for eyedrops. are now available with color caps. The new caps are the same color as Allergan's Propine(R) and Betagan(R), their brand comparisons. The Schein color caps are: Dipivefrin HCI (Human Computer Interaction) Refers to the design and implementation of computer systems that people interact with. It includes desktop systems as well as embedded systems in all kinds of devices. Ophthalmic Solution, 0.1% -- Purple Levobunolol HCI Ophthalmic Solution, 0.25% -- Blue Levobunolol HCI Ophthalmic Solution, 0.5% -- Yellow. Color caps can help prevent potentially serious consequences, such as harmful drug interactions, by enabling patients to distinguish one medication from another, particularly useful when bottle shapes and sizes are similar. In addition, color caps are an aid to individuals with poor eyesight eye·sight n. 1. The faculty of sight; vision. 2. Range of vision; view. , such as the elderly, in identifying the correct medication. Schein Pharmaceutical Inc. is one of the leading multisource companies in the U.S., employing over 1,800 people at seven facilities: Florham Park,; Carmel, N.Y.; Brewster, N.Y.; Danbury, Conn.; Phoenix; Humacao, PR; and Cherry Hill Cherry Hill, township (1990 pop. 69,319), Camden co., W central N.J.; name was changed from Delaware township to Cherry Hill in 1961. Largely residential, Cherry Hill has been marked by great development and housing growth, especially since the 1970s. , N.J. Schein manufactures and markets over 400 pharmaceutical products in nearly every therapeutic category. The company maintains modern manufacturing facilities, invests significantly in product development, and focuses on controlling health care costs through state-of-the-art production, distribution and competitive pricing of quality merchandise. CONTACT: Schein Pharmaceutical Suzanne Soderberg 201/593-5565 201/593-5820 (fax) |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion